Beam Therapeutics Inc. Assets Liabilities Change (Total)

Assets Liabilities Change (Total) of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including Assets Liabilities Change (Total) growth rates and interactive chart.


Highlights and Quick Summary

  • Assets Liabilities Change (Total) for the quarter ending September 30, 2022 was $-3.33 Million (a -62.44% decrease compared to previous quarter)
  • Year-over-year quarterly Assets Liabilities Change (Total) decreased by -108.37%
  • Annual Assets Liabilities Change (Total) for 2021 was $121 Million (a 64.99% increase from previous year)
  • Annual Assets Liabilities Change (Total) for 2020 was $73.5 Million (a -2260.66% decrease from previous year)
  • Annual Assets Liabilities Change (Total) for 2019 was $-3.4 Million (a -113.01% decrease from previous year)
  • Twelve month Assets Liabilities Change (Total) ending September 30, 2022 was $287 Million (a -8.15% decrease compared to previous quarter)
  • Twelve month trailing Assets Liabilities Change (Total) increased by 136.78% year-over-year
Trailing Assets Liabilities Change (Total) for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$287 Million $313 Million $378 Million $121 Million
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Assets Liabilities Change (Total) of Beam Therapeutics Inc.

Most recent Assets Liabilities Change (Total)of BEAM including historical data for past 10 years.

Interactive Chart of Assets Liabilities Change (Total) of Beam Therapeutics Inc.

Beam Therapeutics Inc. Assets Liabilities Change (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-3.33 $-8.87 $259.51
2021 $39.77 $22.14 $56.7 $2.64 $121.24
2020 $62.53 $3.96 $7.96 $-0.96 $73.48
2019 $7.24 $-0.59 $3.91 $-13.96 $-3.4
2018 $26.15 $26.15

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology